NCI-H889 Cells

NCI-H889 is a human small cell lung cancer (SCLC) cell line with neuroendocrine features. It was established from an adult patient and is categorized as a classic SCLC model based on morphological and molecular criteria. The cells grow in suspension and display the round-to-oval morphology typical of SCLC. NCI-H889 expresses several neuroendocrine markers and has been widely used in mechanistic and pharmacologic studies related to this aggressive lung cancer subtype.

Functionally, NCI-H889 is characterized by autocrine signaling through the insulin-like growth factor II (IGF-II) and its receptor IGF-R. While IGF-I mRNA is widely detected among lung cancer cell lines, direct secretion of IGF-I protein is rare; in NCI-H889, the predominant ligand involved in growth stimulation is IGF-II. This is consistent with findings that support IGF-II/IGF-R signaling loops as key drivers of autocrine growth in SCLC cell lines. These autocrine interactions make NCI-H889 a valuable system for studying IGF-mediated mitogenic signaling and its therapeutic disruption.

Epigenetic analyses of NCI-H889 have also provided insight into the regulation of drug response. Methylation profiling indicates alterations in several genes involved in DNA damage response, cell cycle regulation, and transcriptional control. For example, NCI-H889 has been included in studies showing differential methylation and expression of genes like SLFN11, which is associated with sensitivity to DNA-damaging agents, and EZH2, a histone methyltransferase frequently upregulated in SCLC. These characteristics collectively position NCI-H889 as a relevant preclinical model for exploring therapeutic vulnerabilities associated with neuroendocrine lung tumors.